tirzepatide discontinued being FDA has announced that the shortage of #tirzepatide, the ingredient in Lilly's Mounjaro and Zepbound, has been resolved. Compounding #pharmacies are required to cease Discontinuing Zepbound Leads To Weight

Thonneau, P

Retatrutide side effects from TRIUMPH-4 Phase 3 trial data, including the novel dysesthesia signal Common Side Effects (from TRIUMPH-4 Phase 3) Source: Eli Lilly press release and medical information portal (medical.lilly.com), December 11, 2025

Dizziness, fainting, or sudden weakness These can be signs of blood pressure changes or an adverse reaction to the infusion

The other GLP agonists have been looked at for alcohol use disorder, for binge eating disorder, and for a lot of behavioral and impulse control disorders." Andrew Huberman 56% lower risk of new alcohol use disorder diagnoses

Wegovy summary of product characteristics

Why It Matters Ozempic is a prescription drug developed to manage blood sugar levels in patients with Type 2 diabetes